
Opinion|Videos|January 7, 2025
When to Consider Systemic Treatment for Prurigo Nodularis Patients
Author(s)TJ Chao, MPAS, PA-C
TJ Chao, MPAS, PA-C, discusses how systemic treatments for prurigo nodularis are considered for patients with moderate to severe disease, highlighting key patient-specific factors such as comorbidities and disease severity when initiating treatment.
Advertisement
Episodes in this series

Video content above is prompted by the following:
For which type of patient would you consider systemic treatments for prurigo nodularis patients?
What patient-specific factors do you consider when starting treatment?
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
3
10 Skin Cancer Exam Tips
4
Dermatology Times Conferences & Meetings Calendar: September 2026
5





